|
See related Latisse ophth soln information |
|
|
|
Manufacturer |
Allergan |
|
Distributor |
Hong Kong: DKSH |
|
Contents |
Bimatoprost |
|
Indications |
Treatment of hypotrichosis of the eyelashes by increasing the growth including length, thickness & darkness. |
|
Dosage |
Place 1 drop on disposable sterile applicator & apply evenly along the skin of the upper eyelid margin at the base of the eyelashes, once daily in the evening. |
|
Special Precautions |
Concomitant use w/ other prostaglandin analogs for IOP reduction. Possibility of increased iris & periorbital tissue pigmentation. Avoid contact w/ skin surface other than treatment area. Active intraocular inflammation eg uveitis; aphakic or pseudophakic patients w/ torn posterior lens capsule or w/ known risk factors for macular edema. Bacterial keratitis associated w/ container contamination. Contact lenses should be removed prior to application & reinserted 15 min following administration. Pregnancy & lactation. Childn. |
|
Adverse Drug Reactions |
Eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms & erythema of the eyelid.
View ADR Monitoring Form |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
ATC Classification |
S01EE03 - bimatoprost ; Belongs to the class of prostaglandin analogues. Used in the treatment of glaucoma and miosis. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Latisse ophthalmic solution |
|
Latisse 0.3 mg/1 mL x 3 mL |
|
|
|
Manufacturer: |
Allergan |
|
Distributor: |
Hong Kong: DKSH |
|
 |
 |
|
|
